Anzeige
Meldung des Tages: PE-Zugang war nötig! Bekannte kanadische Investorenfamilie Di Battista holte die Plattform an die TSX Venture
21.09.26
Biting into high-margin niches; INITIATE with BUY
Gallmetzer HealthCare (GHC) offers multiple avenues for organic growth and margin expansion . The company is a vertically integrated dental healthcare platform combining a ...
18.09.26
Operations rightsized // profitable growth in sight; chg.
Topic: H1 confirms the pivot from a broad lifestyle group to a focused membership and travel-​services platform. Profitability and cash flow improved despite a sharply lower top line, ...
18.09.26
FY25 falls well short of guidance; rating suspended
Swissnet has published its FY25 report, two months past the statutory deadline and materially below the guided range. More pressing than the miss itself is the liquidity position it ...
15.09.26
H1 optics are worse than operations; chg.
Following Friday's guidance cut, MHP released its H1 report yesterday, confirming the picture. In detail: H1 sales came in at € 99.3m (eNuW: € 98.3m), up 25% yoy. Growth was ...
15.09.26
World Cup to boost growth in Q2 26; chg. est
bet-​at-home.com is to report its Q2 26 figures on 21 September. We expect a quarter of strong top-line growth on the back of the World Cup. In detail: Q2 net revenue is seen to ...
09.09.26
ADES Test Loop with VDL moves into execution
First project-​specific ADES agreement strengthens industrialisation path. Emerald Horizon (SMRX) yesterday officially kicked off the Test Loop programme for ADES, Emerald's ...
07.09.26
New revenue guidance reinforces growth trajectory; chg. est.
Ahead of its AGM today, NanoRepro published group revenue guidance for the short-, medium- and long-term on Friday, providing greater visibility on the expected growth trajectory ...
03.09.26
Nutritional elixirs as third consolidated pillar for NanoRepro
On Tuesday, NanoRepro announced it acquired the remaining 67% of hyped about science GmbH, in which it previously held 33% as an equity stake. In detail: ALPHABIOL under a ...
02.09.26
Stimulating growth with surgical accuracy; INITIATE with BUY
Nexstim is a Finnish MedTech company and a global leader in navigated transcranial magnetic stimulation (nTMS) technology. With nTMS , Nexstim helps (i) surgeons preserve ...
02.09.26
H1'26 review: costs above expectations; est. & PT chg.
Aiforia published its H1'26 report last Friday . Revenue of € 0.75m (-46% yoy) was already known from the July profit warning, which we attributed to the absence of onboarding ...
01.09.26
H1 confirms the case, FCF set to grow strongly; chg.
Yesterday, LIMES published its H1'25 report, showing continued top-line expansion thanks to the new clinics as well as strong profitability despite the ramp-up of those. In detail: H1 ...
31.08.26
Renewable fuels entering a new cycle; INITIATE WITH BUY
VERBIO is one of Europe's leading integrated biorefineries , converting agricultural feedstocks and residues into biodiesel, bioethanol, biomethane, renewable chemicals and ...
31.08.26
H1 review: profitable Q2 marks earnings inflection
Final H1 results show that LAIQON's enlarged platform has reached a clear earnings inflection. Positive Q2 EBITDA demonstrates that the higher AuM base is now translating into ...
26.08.26
Test Loop with VDL kicks off the next phase of ADES development
Emerald Horizon (SMRX) has announced the start of its ADES Test Loop programme together with industrial partner VDL Groep. According to the company, the Test Loop will ...
25.08.26
Early CL exit weighs on FY25/26p; chg.
On Friday, BVB published preliminary FY25/26 figures, showing a declining top line and profitability on the back of the early UCL exit. In detail: FY25/26p sales declined 12.5% yoy to € ...
24.08.26
H1 review: Back on the growth path, data centres pulling
Nabaltec reported H1 figures, which confirm the guided return to growth from Q2. Despite higher energy costs and increased depreciation levels, the Q2 EBIT margin points towards ...
24.08.26
Portfolio unwound; rating placed Under Review
SYNBIOTIC's investment case has changed fundamentally after a wave of insolvencies and liquidations across the portfolio. What began with the Bushdoctor (Austria) insolvency in ...
21.08.26
Final Q2: More detail, same picture
Following last week's guidance cut and preliminary H1 figures, NFON yesterday released its H1 report. In detail: Top line came in as pre-​released, with Q2 sales down 5.2% yoy to € ...
21.08.26
US drives H1 eCons beat // strong H2 set-up
tonies delivered a strong Q2, with group revenue of € 117m, +49% yoy (cc) ahead of consensus (€ 108m). TB2 momentum remained exceptional, and figurine demand is accelerating, ...
20.08.26
Standing tall in a critical niche; INITIATE WITH BUY
SMAG is a rare pure-play on the mobile communications infrastructure behind the digital battlefield. Many tactical radio links depend on line of sight, making antenna height critical to ...